In addition to the increased deletion rates of CDKN2A and CDKN2B in MM [117,145], the amplification of MYC, kDR, KIT, PDGFRA, MITF, VEGF and CCND3 is also common [14,117]. Here, CDKN2A is linked to Miyoshi myopathy.